MedPath

MYLAN INSTITUTIONAL INC.

🇺🇸United States
Ownership
Private
Established
1980-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

46

FDA:46

Drug Approvals

Methotrexate

Approval Date
Jan 11, 2024
FDA

Clozapine

Approval Date
Jan 11, 2024
FDA

Chlordiazepoxide Hydrochloride

Approval Date
Jan 10, 2024
FDA

Carbidopa and Levodopa

Approval Date
Jan 3, 2024
FDA

Buspirone Hydrochloride

Approval Date
Dec 27, 2023
FDA

Atenolol

Approval Date
Dec 27, 2023
FDA

Isoniazid

Approval Date
Dec 27, 2023
FDA

Clozapine

Approval Date
Dec 27, 2023
FDA

Allopurinol

Approval Date
Dec 27, 2023
FDA

Verapamil Hydrochloride

Approval Date
Dec 27, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.